LEAMINGTON, ON, Oct. 27, 2017
/CNW/ - Aphria Inc. ("Aphria" or the "Company")
(TSX: APH or USOTCQB: APHQF) is pleased to
announce that Renah Persofsky and
Shawn Dym were elected as new
directors at the Company's annual general and special meeting held
on October 25, 2017.
Ms. Persofsky is an executive consultant in the Innovation Group
at CIBC. She is a widely-respected entrepreneur and
strategist with a successful track record of creating 27 start-up
companies and a rich history of investing in early stage companies.
Ms. Persofsky serves as Board Chair for mobile on-demand
senior care and child care start-up BookJane, advises award winning
payment card and platform technology firm Dynamics Inc., and is a
board member for retail/QSR automation software specialty firm
MeazureUp Inc.
Mr. Dym is a managing director at York Plains Investment Corp.,
a private investment vehicle focused on maximizing absolute returns
by investing in a wide array of asset classes, including successful
cannabis related investments. He currently serves on the
board of advisors for Green Acre Capital, Canada's first private investment fund focused
on the cannabis industry, as well as the board of directors at
Wellpoint Health and Totally Green.
"We are pleased to welcome Renah and Shawn to Aphria's Board of
Directors. Together, they bring valuable capital
markets and cannabis industry expertise that will be instrumental
in driving Aphria's strategic direction as a global leader in the
cannabis industry. Their passion for success in growing
dynamic companies will be a tremendous asset to the board," said
Vic Neufeld, Chief Executive Officer
of Aphria.
About Aphria
Aphria Inc., one of Canada's
lowest cost producers, produces, supplies and sells medical
cannabis. Located in Leamington,
Ontario, the greenhouse capital of Canada. Aphria is
truly powered by sunlight, allowing for the most natural growing
conditions available. We are committed to providing
pharma-grade medical cannabis, superior patient care while
balancing patient economics and returns to shareholders.
For more information, visit www.Aphria.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain
information in this news release constitutes forward-looking
statements under applicable securities laws. Any statements that
are contained in this news release that are not statements of
historical fact may be deemed to be forward-looking statements.
Forward-looking statements are often identified by terms such as
"may", "should", "anticipate", "expect", "potential", "believe",
"intend" or the negative of these terms and similar expressions.
Forward-looking statements in this news release include, but are
not limited to, statements with respect to internal expectations,
estimated margins, expectations for future growing capacity and
costs, the completion of any capital project or expansions, any
commentary related to the legalization of cannabis and the timing
related thereto, expectations of Health Canada approvals and
expectations with respect to future production costs.
Forward-looking statements necessarily involve known and unknown
risks, including, without limitation, risks associated with general
economic conditions; adverse industry events; marketing costs; loss
of markets; future legislative and regulatory developments
involving medical cannabis or adult use of cannabis; inability to
access sufficient capital from internal and external sources,
and/or inability to access sufficient capital on favourable terms;
the medical cannabis industry in Canada generally, income tax and regulatory
matters; the ability of Aphria to implement its business
strategies; competition; crop failure; currency and interest rate
fluctuations and other risks.
Readers are cautioned that the foregoing list is not exhaustive.
Readers are further cautioned not to place undue reliance on
forward-looking statements as there can be no assurance that the
plans, intentions or expectations upon which they are placed will
occur. Such information, although considered reasonable by
management at the time of preparation, may prove to be incorrect
and actual results may differ materially from those anticipated.
Forward-looking statements contained in this news release are
expressly qualified by this cautionary statement.
SOURCE Aphria Inc.